160 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27997171	48	Pyrimidine-Based Inhibitors of Dynamin I GTPase Activity: Competitive Inhibition at the Pleckstrin Homology Domain.	The University of Newcastle
28045525	54	A Macrocyclic Agouti-Related Protein/[Nle	University of Minnesota
27876250	60	Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH	Jagiellonian University Medical College
26988801	55	Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.	Jagiellonian University Medical College
26390077	42	Tactical Approaches to Interconverting GPCR Agonists and Antagonists.	University of Minnesota
26218460	264	Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.	University of Arizona
25699148	41	Azepinone-Containing Tetrapeptide Analogues of Melanotropin Lead to Selective hMC4R Agonists and hMC5R Antagonist.	Vrije Universiteit Brussel
24881566	140	Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).	Glaxosmithkline
25438759	38	Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor.	University of Arizona
24517312	98	Identification of tetrapeptides from a mixture based positional scanning library that can restore nM full agonist function of the L106P, I69T, I102S, A219V, C271Y, and C271R human melanocortin-4 polymorphic receptors (hMC4Rs).	University of Florida
23524643	3	Multivalent Interactions: Synthesis and Evaluation of Melanotropin Multimers - Tools for Melanoma Targeting.	Universit£
15974575	127	Peptoid-peptide hybrids as potent novel melanocortin receptor ligands.	Utrecht University
22335602	93	Identification and in vivo and in vitro characterization of long acting and melanocortin 4 receptor (MC4-R) selectivea-melanocyte-stimulating hormone (a-MSH) analogues.	Novo Nordisk
22551631	18	Automated generation of turn mimetics: proof of concept study for the MC4 receptor.	Neurocrine Biosciences
20684563	176	Discovery of N-{1-[3-(3-oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.	H. Lundbeck
20547453	122	Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain.	University of Arizona
20329799	176	Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans.	Pfizer
20172734	22	A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.	Glaxosmithkline
19473029	110	Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor.	University of Arizona
18412316	52	Design and microwave-assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists.	University of Arizona
18220330	28	Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity.	The Hebrew University of Jerusalem
18032040	49	Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
18479920	68	Synthesis and SAR of potent and orally bioavailable tert-butylpyrrolidine archetype derived melanocortin subtype-4 receptor modulators.	Merck Research Laboratories
18078748	41	Synthesis and biological activity of novel peptide mimetics as melanocortin receptor agonists.	Nanyang Technological University
18088090	72	Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.	University of Arizona
17267226	46	Novel piperazines: potent melanocortin-4 receptor antagonists with anxiolytic-like activity.	Taisho Pharmaceutical
16678415	21	Design of cyclic peptides with agonist activity at melanocortin receptor-4.	Asahi Kasei Pharma
16451057	140	Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation.	Millennium Pharmaceuticals
15771429	104	Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.	University of Arizona
15808454	49	2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists.	Merck Research Laboratories
15911261	62	Design, synthesis, and evaluation of proline based melanocortin receptor ligands.	Procter & Gamble Pharmaceuticals
15582434	37	Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist.	Merck Research Laboratories
15482933	55	Piperazinebenzylamines as potent and selective antagonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
13678399	54	Peptide science: exploring the use of chemical principles and interdisciplinary collaboration for understanding life processes.	University of Arizona
12904077	75	Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R.	University of Arizona
12431055	52	Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors.	University of Arizona
12036373	72	Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors.	University of Arizona
11150170	30	D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity.	University of Arizona
9216831	60	Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.	University of Michigan Medical Center
9171884	52	Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.	University of Michigan Medical Center
7658432	46	Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors.	University of Arizona
14643340	41	Design and syntheses of melanocortin subtype-4 receptor agonists: evolution of the pyridazinone archetype.	Merck Research Laboratories
14552781	45	Aryl piperazine melanocortin MC4 receptor agonists.	Neurocrine Biosciences
12873485	150	Sub-nanomolar hMC1R agonists by end-capping of the melanocortin tetrapeptide His-D-Phe-Arg-Trp-NH(2).	University of Cincinnati
12824029	21	Design of a new peptidomimetic agonist for the melanocortin receptors based on the solution structure of the peptide ligand, Ac-Nle-cyclo[Asp-Pro-DPhe-Arg-Trp-Lys]-NH(2).	Amgen
12467633	58	Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.	Roche Research Center
11909712	124	N-alkylaminoacids and their derivatives interact with melanocortin receptors.	Uppsala University
12161144	23	Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: arginine substitution.	Roche Research Center
22011200	24	Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.	H. Lee Moffitt Cancer Center & Research Institute
21940174	4	A sucrose-derived scaffold for multimerization of bioactive peptides.	The University of Arizona
21928837	11	Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment.	Universit£
20598882	76	Spiroindane based amides as potent and selective MC4R agonists for the treatment of obesity.	Merck Research Laboratories
21486697	17	Cyclic lactam hybrida-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptors.	University of Arizona
21439820	43	Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist.	Merck Research Laboratories
21277204	16	Serendipitous discovery of a new class of agonists for the melanocortin 1 and 4 receptors and a new class of cyclophanes.	Novo Nordisk
20933410	22	Discovery of highly potent and efficacious MC4R agonists with spiroindane N-Me-1,2,4-triazole privileged structures for the treatment of obesity.	Merck Research Laboratories
20813948	63	Spiroindolones, a potent compound class for the treatment of malaria.	Swiss Tropical and Public Health Institute
20621473	56	Discovery of potent, selective, and orally bioavailable 3H-spiro[isobenzofuran-1,4'-piperidine] based melanocortin subtype-4 receptor agonists.	Merck Research Laboratories
20598533	71	Optimization of privileged structures for selective and potent melanocortin subtype-4 receptor ligands.	Merck Research Laboratories
20591666	66	A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.	Università
20207541	18	Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist.	Merck Research Laboratories
18771254	153	Discovery of orally bioavailable 1,3,4-trisubstituted 2-oxopiperazine-based melanocortin-4 receptor agonists as potential antiobesity agents.	Procter & Gamble Pharmaceuticals
18682322	93	Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.	Neurocrine Biosciences
18417348	82	Pharmacological and pharmacokinetic characterization of 2-piperazine-alpha-isopropyl benzylamine derivatives as melanocortin-4 receptor antagonists.	Neurocrine Biosciences
18294847	61	Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.	Neurocrine Biosciences
18082401	46	Syntheses of tetrahydrothiophenes and tetrahydrofurans and studies of their derivatives as melanocortin-4 receptor ligands.	Neurocrine Biosciences
17994683	55	Design, synthesis, in vitro, and in vivo characterization of phenylpiperazines and pyridinylpiperazines as potent and selective antagonists of the melanocortin-4 receptor.	Neurocrine Biosciences
17964151	107	Synthesis and characterization of trans-4-(4-chlorophenyl)pyrrolidine-3-carboxamides of piperazinecyclohexanes as ligands for the melanocortin-4 receptor.	Neurocrine Biosciences
17933528	68	Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
17918824	39	Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexia.	Neurocrine Biosciences
17822895	110	Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
17768046	70	Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.	Merck
17629702	68	Pyrrolidines as potent functional agonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
17618123	674	Design and synthesis of a library of tertiary amides: evaluation as mimetics of the melanocortins' active core.	Uppsala University
17574418	117	Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.	Institut Henri Beaufour
17544282	39	Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activity.	Neurocrine Biosciences
17455928	171	Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.	Merck Research Laboratories
17448660	8	Squalene-derived flexible linkers for bioactive peptides.	University of Arizona
17314042	40	Novel selective human melanocortin-3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold.	Vrije Universiteit Brussel
17234422	118	Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor.	Taisho Pharmaceutical
17154518	27	Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor.	University of Arizona
16931008	72	Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors.	University of Arizona
16876401	48	Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity.	Jerini
16854081	216	Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach.	Procter & Gamble Pharmaceuticals
16824757	67	Propionylpiperazines as human melanocortin-4 receptor ligands.	Neurocrine Biosciences
16777413	65	Arylpropionylpiperazines as antagonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
16766182	108	Design and synthesis of potent and selective 1,3,4-trisubstituted-2-oxopiperazine based melanocortin-4 receptor agonists.	Procter & Gamble Pharmaceuticals
16697187	46	Design, synthesis, and SAR studies on a series of 2-pyridinylpiperazines as potent antagonists of the melanocortin-4 receptor.	Neurocrine Biosciences
16697186	17	Privileged structure based ligands for melanocortin receptors--4,4-disubstituted piperidine derivatives.	Eli Lilly
16650763	27	Privileged structure based ligands for melanocortin-4 receptors--aliphatic piperazine derivatives.	Eli Lilly
16539382	136	Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.	University of Arizona
16458508	52	Identification and structure-activity relationships of a new series of Melanocortin-4 receptor antagonists.	Millennium Pharmaceuticals
16376076	40	Synthesis of Tic-D-Phe Psi[CH2-CH2] isostere and its use in the development of melanocortin receptor agonists.	Procter & Gamble Pharmaceuticals
16364639	101	Optimization of a privileged structure leading to potent and selective human melanocortin subtype-4 receptor ligands.	Merck Research Laboratories
16297618	32	Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptor.	Eli Lilly
16203134	37	Preparation of human Melanocortin-4 receptor agonist libraries: linear peptides X-Y-DPhe7-Arg8-Trp(or 2-Nal)9-Z-NH2.	Roche Research Center
16183282	47	Structure-activity relationship studies on a series of cyclohexylpiperazines bearing a phanylacetamide as ligands of the human melanocortin-4 receptor.	Neurocrine Biosciences
16169218	30	Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides.	Roche Research Center
16169215	27	Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives.	Eli Lilly
16112861	2	Privileged structure-based ligands for melanocortin receptors-tetrahydroquinolines, indoles, and aminotetralines.	Eli Lilly
16005624	97	Design and syntheses of melanocortin subtype-4 receptor agonists. Part 2: discovery of the dihydropyridazinone motif.	Merck Research Laboratories
15982875	46	Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-2-methyl-2-azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4 receptor agonist.	Merck Research Laboratories
15951175	28	1-Amino-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid as a Tic mimetic: application in the synthesis of potent human melanocortin-4 receptor selective agonists.	Merck Research Laboratories
15950470	69	Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
15863313	65	A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.	Neurocrine Biosciences
15857110	96	Discovery of a beta-MSH-derived MC-4R selective agonist.	Eli Lilly
15745810	39	Melanocortin subtype-4 receptor agonists containing a piperazine core with substituted aryl sulfonamides.	Amgen
15664867	33	Identification of agonists and antagonists of the human melanocortin-4 receptor from piperazinebenzylamines.	Neurocrine Biosciences
15615531	30	4-{(2R)-[3-Aminopropionylamido]-3-(2,4-dichlorophenyl)propionyl}-1-{2-[(2-thienyl)ethylaminomethyl]phenyl}piperazine as a potent and selective melanocortin-4 receptor antagonist--design, synthesis, and characterization.	Neurocrine Biosciences
15357964	90	Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptor.	Neurocrine Biosciences
15341935	138	End-capping of the modified melanocortin tetrapeptide (p-Cl)Phe-D-Phe-Arg-Trp-NH2 as a route to hMC4R agonists.	University of Cincinnati
15317471	42	New substituted piperazines as ligands for melanocortin receptors. Correlation to the X-ray structure of"THIQ".	Uppsala University
15267247	55	Phenylguanidines as selective nonpeptide melanocortin-5 receptor antagonists.	Neurocrine Biosciences
15203150	18	Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R).	Millennium Pharmaceuticals
14761190	10	Recognition of privileged structures by G-protein coupled receptors.	Novo Nordisk
14736255	68	Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.	Eli Lilly
14698163	60	Synthesis of novel melanocortin 4 receptor agonists and antagonists containing a succinamide core.	Amgen
14684330	17	Novel targeting strategy based on multimeric ligands for drug delivery and molecular imaging: homooligomers of alpha-MSH.	University of Arizona
14643322	24	beta-alanine dipeptides as MC4R agonists.	Bristol-Myers Squibb Pharmaceutical Research Institute
14584947	108	Structure-activity relationships of gamma-MSH analogues at the human melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues.	University of Arizona
12668001	17	Peptoid mimics of agouti related protein.	University of California
12657270	57	Structure-activity relationship of cyclic peptide penta-c[Asp-His(6)-DPhe(7)-Arg(8)-Trp(9)-Lys]-NH(2) at the human melanocortin-1 and -4 receptors: His(6) substitution.	Roche Research Center
12646021	35	Discovery of tyrosine-based potent and selective melanocortin-1 receptor small-molecule agonists with anti-inflammatory properties.	Bristol-Myers Squibb Pharmaceutical Research Institute
12639550	55	Structure-activity relationship of linear peptide Bu-His6-DPhe7-Arg8-Trp9-Gly10-NH2 at the human melanocortin-1 and -4 receptors: DPhe7 and Trp9 substitution.	Roche Research Center
12502354	30	Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding.	Amgen
12361385	34	Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist.	Merck
11909711	86	Reductive amination products containing naphthalene and indole moieties bind to melanocortin receptors.	Uppsala University
11606131	92	Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro.	Merck Research Laboratories
32602722	8	A Venomics Approach Coupled to High-Throughput Toxin Production Strategies Identifies the First Venom-Derived Melanocortin Receptor Agonists.	Universit£
29851477	6	New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm.	Astrazeneca
31845801	78	Incorporation of Agouti-Related Protein (AgRP) Human Single Nucleotide Polymorphisms (SNPs) in the AgRP-Derived Macrocyclic Scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Decreases Melanocortin-4 Receptor Antagonist Potency and Results in the Discovery of Melanocortin-5 Receptor Antagonists.	University of Minnesota
29669202	24	Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over ?-Arrestin 2 Recruitment) Within the Melanocortin Receptors.	University of Minnesota
26599352	35	Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor.	Universit£
23890524	24	Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.	University of Arizona
23489620	8	Synthesis and evaluation of cholecystokinin trimers: a multivalent approach to pancreatic cancer detection and treatment.	Universit£
12801221	16	QSAR and proteo-chemometric analysis of the interaction of a series of organic compounds with melanocortin receptor subtypes.	Uppsala University
29679901	74	Replacement of Arg with Nle and modified D-Phe in the core sequence of MSHs, Ac-His-D-Phe-Arg-Trp-NH	University of Arizona
29660981	122	Development of Macrocyclic Peptidomimetics Containing Constrained ?,?-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors.	University of Naples "Federico Ii
29631962	252	Identification and biological evaluation of thiazole-based inverse agonists of ROR?t.	Phenex Pharmaceuticals
28453292	163	Discovery of Mixed Pharmacology Melanocortin-3 Agonists and Melanocortin-4 Receptor Tetrapeptide Antagonist Compounds (TACOs) Based on the Sequence Ac-Xaa	University of Minnesota
29605997	160	Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.	The University of Queensland
29578343	32	Human?-Defensin 1 and?-Defensin 3 (Mouse Ortholog mBD14) Function as Full Endogenous Agonists at Select Melanocortin Receptors.	University of Florida
29094944	98	Design of MC1R Selective?-MSH Analogues with Canonical Amino Acids Leads to Potency and Pigmentation.	The University of Arizona
28972753	82	Click-Chemistry-Mediated Synthesis of Selective Melanocortin Receptor 4 Agonists.	University of Copenhagen
19226504	5	On-chip fragment-based approach for discovery of high-affinity bivalent inhibitors.	Antibiotics Laboratory
7566488	30	Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity.	Merz
19354253	13	Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.	Vanderbilt University
17403688	6	Insights into the mechanism of partial agonism: crystal structures of the peroxisome proliferator-activated receptor gamma ligand-binding domain in the complex with two enantiomeric ligands.	Consiglio Nazionale Delle Ricerche